Bristol Myers (BMY) stock gains after Q4 results beat Street view

Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement. The pharmaceutical company reported a 39% growth in fourth-quarter revenue of $11.1 billion, which surpassed Wall Street’s consensus forecast. Consequently, adjusted earnings rose 20% annually to $1.46 per share from $1.22 per share […]

$BMY February 4, 2021 1 min read

NYSE

$BMY · Earnings

“
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement. The pharmaceutical company reported a 39% growth in fourth-quarter revenue of $11.1 billion, which surpassed Wall Street’s consensus forecast. Consequently, adjusted earnings rose 20% annually to $1.46 per share from $1.22 per share […]
· February 4, 2021

Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement.

Bristol Myers Q4 2020 earnings infographic

The pharmaceutical company reported a 39% growth in fourth-quarter revenue of $11.1 billion, which surpassed Wall Street’s consensus forecast. Consequently, adjusted earnings rose 20% annually to $1.46 per share from $1.22 per share in the fourth quarter of 2019.

On an unadjusted basis, it was a net loss of $10.0 billion or $4.45 per share, compared to a loss of $1.1 billion or $0.55 per share last year.

Read management/analysts’ comments on Bristol Myers’ Q4 report

BMY shares gained 1% immediately after the announcement early Thursday. The stock had closed the previous session lower.